In addition, future studies should complement the α-SMA/TAGLN double-staining assay in human lung cancer tissues, and subject the staining results to multivariate analysis in relation to clinical variables to further correct for tumor cellularity. The gene discussed is TAGLN; the disease is lung cancer.